Trials / Completed
CompletedNCT05306366
A Brain Imaging PET Study of [11C]-Lu AF90103 in Healthy Adult Male Participants
Interventional Open-Label Positron Emission Tomography Study Investigating Blood-Brain-Barrier Penetration and Pharmacokinetic Properties of [11C]-Lu AF90103 in Healthy Young Men
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- H. Lundbeck A/S · Industry
- Sex
- Male
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The main goals of the study are to assess uptake and distribution of Lu AF90103 in the brain when given at tracer levels (microdose) in healthy young men.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | [11C]-Lu AF90103 | PET ligand administrated as a single intravenous bolus injection |
Timeline
- Start date
- 2022-03-23
- Primary completion
- 2022-06-07
- Completion
- 2022-06-07
- First posted
- 2022-04-01
- Last updated
- 2022-07-14
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT05306366. Inclusion in this directory is not an endorsement.